statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Orchestra BioMed Holdings ( NASDAQ:OBIO ) Full Year 2023 Results Key Financial Results Net loss: US$49.1m (loss widened...

Orchestra BioMed Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Initiated enrollment of the BACKBEAT global pivotal study evaluating AVIM therapy (also known as BackBeat Cardiac Neuromodulation Therapy) in hypertensive pacemaker patients in collaboration with...

Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update

David Pacitti is currently the President of Siemens Medical Solutions USA, Inc. and Head of the Americas, Siemens Healthineers; formerly Division Vice President of U.S. Commercial Operations, Sales...

Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors

New pharmacokinetic data demonstrate Virtue SAB enables extended release of sirolimus above required tissue concentrations in target arterial sites without polymer degradation or detectable...

Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue  SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting

NEW HOPE, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, Orchestra BioMed or the Company ), a biomedical company accelerating high-impact technologies to...

Orchestra BioMed to Participate in Upcoming Investor Conferences

Clinical study evaluated impact of AVIM therapy as compared to standard pacing using invasive pressure-volume loop analysis in 16 hypertensive pacemaker-indicated patients Results demonstrate...

Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients

8.9 mmHg mean reduction in 24-Hour ambulatory systolic blood pressure at average of 3.6 years from initiation of AVIM therapy in patients who participated in the MODERATO II study Orchestra BioMed is...

Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over 3 Years

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO  Get Free Report) saw a significant decline in short interest during the month of January. As of January 15th, there was short interest totalling...

Short Interest in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Decreases By 12.8%

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO  Get Free Report) saw a significant drop in short interest during the month of January. As of January 15th, there was short interest totalling...

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Short Interest Down 12.8% in January

In trading on Monday, shares of Orchestra BioMed Holdings Inc (OBIO) crossed above their 200 day moving average of 9.38, changing hands as high as 10.01 per share. Orchestra BioMed...

Orchestra BioMed Holdings Breaks Above 200-Day Moving Average - Bullish for OBIO

Orchestra Biomed Holdings, Inc. engages in the provision of biomedical technologies to patients through risk-reward-sharing partnerships with medical device companies. The company was founded on May 25, 2020 and is headquartered in New Hope, PA.

Volume	2,378.00
52-Wk High	$20.19
52-Wk Low	$4.26

OBIO Orchestra BioMed Holdings Inc

About

Feed

News

Sentiment

Fundamentals